These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 9252692
1. MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1. Xie W, Su K, Wang D, Paterson AJ, Kudlow JE. Anticancer Res; 1997; 17(4A):2627-33. PubMed ID: 9252692 [Abstract] [Full Text] [Related]
2. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Flørenes VA, Lu C, Bhattacharya N, Rak J, Sheehan C, Slingerland JM, Kerbel RS. Oncogene; 1999 Jan 28; 18(4):1023-32. PubMed ID: 10023678 [Abstract] [Full Text] [Related]
3. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP. Cancer Res; 1997 Mar 01; 57(5):978-87. PubMed ID: 9041204 [Abstract] [Full Text] [Related]
7. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Johnson MR, Valentine C, Basilico C, Mansukhani A. Oncogene; 1998 May 01; 16(20):2647-56. PubMed ID: 9632141 [Abstract] [Full Text] [Related]
10. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Lee TH, Chuang LY, Hung WC. Oncogene; 2000 Aug 03; 19(33):3766-73. PubMed ID: 10949931 [Abstract] [Full Text] [Related]
13. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R. Cell Growth Differ; 1997 Dec 03; 8(12):1267-76. PubMed ID: 9419415 [Abstract] [Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 03; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
17. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells. Toyoda M, Gotoh N, Handa H, Shibuya M. Biochem Biophys Res Commun; 1998 Sep 18; 250(2):430-5. PubMed ID: 9753647 [Abstract] [Full Text] [Related]
18. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells. Schaber JD, Fang H, Xu J, Grimley PM, Rui H. Cancer Res; 1998 May 01; 58(9):1914-9. PubMed ID: 9581833 [Abstract] [Full Text] [Related]
19. EGF-induced activation of Stat1, Stat3, and Stat5b is unrelated to the stimulation of DNA synthesis in cultured hepatocytes. Guren TK, Abrahamsen H, Thoresen GH, Babaie E, Berg T, Christoffersen T. Biochem Biophys Res Commun; 1999 May 19; 258(3):565-71. PubMed ID: 10329425 [Abstract] [Full Text] [Related]
20. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling. Zhang T, Ma J, Cao X. Biochem J; 2003 Dec 01; 376(Pt 2):457-64. PubMed ID: 14498832 [Abstract] [Full Text] [Related] Page: [Next] [New Search]